Molecular Imaging is on a bit of a hiring spree, looking to hire 10 people today as it looks to scale up its services.
The Ann Arbor-based company provides in vivo pre-clinical imaging services for pharmaceutical, biotechnology and medical device companies. A group of venture capital firms acquired Molecular Imaging 2.5 years ago. Farmington Hills-based
Beringea led that group of investors making the acquisition.
"We plan to scale up our services and add some new services," says Patrick McConville, CSO & senior vice president of
Molecular Imaging.
Molecular Imaging has already enjoyed some repeat business from its existing customer base. It has also been diversifying its client base to set the stage for growth. McConville expects the company to double in size over the next year so the company is looking to add 10 positions to its existing staff of about 30 people to facilitate that growth. The open positions include a director, accounts manager and eight scientists.
"These are scientists focused on executing our studies," McConville says.
Source: Patrick McConville, CSO & senior vice president of Molecular Imaging
Writer: Jon Zemke
Read more about Metro Detroit's growing entrepreneurial ecosystem at SEMichiganStartup.com.
Enjoy this story?
Sign up for free solutions-based reporting in your inbox each week.